Overview
The Complexities of Safely Processing Highly Potent Molecules and Key Considerations when Choosing an Outsourcing Partner. The pharmaceutical landscape continues to evolve with R&D pipelines producing New Chemical Entities (NCEs) for a wide range of disease states. The market has seen a shift towards more specialist medicines such as oncological and neurological products, in turn leading to an increase in the number of potent compounds requiring expert management. With the complexities involved in the management of potent molecules and the regulatory requirements to ensure safe handing, it is imperative to use the right partner for successful development and manufacturing of highly potent molecules.
Learning Objectives:
- Understand the complexities of processing of highly potent molecules
- Understand the regulatory requirements for the safe handling of highly potent molecules
- Understand the key considerations when choosing a potential outsourcing partner for successful development and manufacturing
